aktien-community.com

[nostradamus]

Teva Wins Generic Uceris® Patent Trial


JERUSALEM--(BUSINESS WIRE)--Oct. 31, 2017-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced that the United States District Court for the District of Delaware has ruled in the Company’s favor in patent litigation involving Teva’s abbreviated new drug application (ANDA) directed to a generic version of Valeant’s Uceris® (budesonide ER) tablets. At trial in May, the Court found that Plaintiffs did not meet the threshold to establish infringement, and the Court has now issued its written decision confirming that Teva’s ANDA product does not infringe the asserted patent.

“We are pleased to have another legal win on one of our first-to-file PIV patent challenges brought in through the Actavis Generics acquisition.” said Dipankar Bhattacharjee, President and CEO, Global Generic Medicines, Teva. “This presents another first generic opportunity for Teva and we look forward to offering this product to our customers when otherwise able to.”

Based on available information, Teva believes it is a "first applicant" to file an ANDA for the generic version of Uceris®. Should its ANDA be approved, Teva may be entitled to 180 days of generic market exclusivity.

Uceris® had annual sales of approximately $191 million in the U.S., according to IMS data as of September 2017.

With nearly 600 generic medicines available, Teva has the largest portfolio of FDA-approved generic products on the market. Teva has over 300 product registrations pending FDA approval and holds the leading position in first-to-file opportunities, with over 100 pending first-to-files in the U.S. Currently, one in seven generic prescriptions dispensed in the U.S. is filled with a Teva generic product.

[Hebi55]

Aus diesen und anderen Gründen kauft Novaris AAA und nicht Cosmo Pharma. Ein Trauerspiel hier.

[kosh]

[jheimi]

Das würde mich auch intetessieren..

[kosh]

[Dilbert]

Rechtliches Hick-Hack in/mit USA - um Patente - ohjemine, das tönt nach Nerven-, Kräfte- und Geld-Raub.


Aber hier dafür noch ein "Anti-Depressivum" by Cosmo:
http://www.cosmopharma.com/~/media/File ... MMX_GE.pdf


Gruss
Dilbert

[jheimi]

Auf dem aktuellen Niveau weist Cosmo eine Marktkap. von ca.2Mia.CHF auf.
Zum Vergleich, Idorsia hat eine Markkap. von aktuell 2.4Mrd.CHF, dabei noch kein Produkt weiter als Phase 2.

Irgendwie stimmen die Relationen überhaupt nicht. Das Potential von Cosmo wird entweder total falsch eingeschätzt oder wir sind alles Träumer.

[hampistravelservice]

Nachbörslich:
668 17:31:27 141.60 17'000

ergibt eine Transaktion über 2'400'000

wünsche ein schönes Weekend

[jheimi]

Das war nicht nachbörslich, sondern in der Schlussauktion und hat wohl nicht viel zu bedeuten.

[hampistravelservice]

Richtig, aber trotz allem in einem Trade gleich viel Umsatz wie den ganzen Tag